Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis. Gobbini MI, Smith ME, Richert ND, Frank JA, McFarland HF J Neuroimmunol. 1999 Sep 1; 99(1):142-9. PMID: 10496187. Abstract CommentRecommendBookmarkWatch